MiT-TFE/LRRK2 Lysosomal Enhancement Therapy
🧪 Overview
LRRK2 inhibition to restore MiT-TFE-mediated lysosomal function in microglia
Debate provenance: derived from debate `sess_SDA-2026-04-03-gap-immune-atlas-neuroinflam-20260402` on question: Comprehensive analysis of immune cell subtypes in neurodegeneration: microglia subtypes (DAM, homeostatic, inflammatory), astrocyte reactivity states, T-cell infiltration. Anchor to existing TREM2 (h-b234254c, h-044ee057) and complement cascade hypotheses (h-58e4635a, h-1fe4ba9b, h-5a55aabc). Produc. Consensus signal: domain_expert, skeptic, synthesizer, theorist discussed the mechanism terms Enhancement, LRRK2, Lysosomal, MiT-TFE, TFE, TFE/LRRK2, inhibition, lysosomal. Novelty signal: skeptic-discussed-with-qualified-concession.
🧬 Mechanism
Auto-built from this analysis's top knowledge-graph edges.
graph TD
LRRK2["LRRK2"] -.->|inhibits| lysosome_degradation["lysosome degradation"]
LRRK2_1["LRRK2"] -.->|inhibits| MiT_TFE["MiT-TFE"]
LRRK2_2["LRRK2"] -.->|inhibits| lysosomal_function["lysosomal_function"]
style LRRK2 fill:#ce93d8,stroke:#333,color:#000
style lysosome_degradation fill:#4fc3f7,stroke:#333,color:#000
style LRRK2_1 fill:#ce93d8,stroke:#333,color:#000
style MiT_TFE fill:#4fc3f7,stroke:#333,color:#000
style LRRK2_2 fill:#ce93d8,stroke:#333,color:#000
style lysosomal_function fill:#4fc3f7,stroke:#333,color:#000⚖️ Evidence
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — LRRK2
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for LRRK2.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
📊 Market Indicators
💾 Resource Usage
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_round_mining
| source | v1_phase_c_backfill |
| origin_type | debate_round_mining |
| _schema_version | 1 |